Jamaica Plain, MA, United States of America

Samuel E Lynch

This inventor holds 11 USPTO granted patents. Top assignees: Harvard College, Institute of Molecular Biology, Inc., Institute of Moelcular Biology, Inc.. Active years: 1989-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Samuel E Lynch. Retrieved from https://idiyas.com/inventor/samuel-e-lynch-1d5czkss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 8

Forward Citations = 441(Granted Patents)

Location History:

Jamaica Plain, MA (US) (1989 - 1992)
Grafton, MA (US) (1996 - 1997)
Beverly, MA (US) (1993 - 2003)

Company Filing History:

Institute of Molecular Biology, Inc.

patents

1 out of 1

Institute of Moelcular Biology, Inc.

patent

where one patent can have more than one assignee

Years Active: 1989-2003

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6506727 - Nerve regeneration (2003-01-14),

2. 5656605 - Device to promote drug-induced nerve regeneration (1997-08-12),

3. 5516699 - Pyridinoline crosslinks as markers of periodontal and peri-implant (1996-05-14),

4. 5256644 - Wound healing using IGF-II and TGF (1993-10-26),

5. 5124316 - Method for periodontal regeneration (1992-06-23),

6. 5035887 - Wound healing composition of IL-1 and PDGF or IGF-1 (1991-07-30),

7. 5034375 - Process of wound healing using PDGF and EGF (1991-07-23),

8. 5019559 - Wound healing using PDGF and IGF-II (1991-05-28),

9. 4983581 - Wound healing composition of IGF-I and TGF-.beta. (1991-01-08),

10. 4874746 - Wound headling composition of TGF-alpha and PDGF (1989-10-17),

11. 4861757 - Wound healing and bone regeneration using PDGF and IGF-I (1989-08-29),

Title: The Innovative Contributions of Samuel E. Lynch

Introduction

Samuel E. Lynch is a notable inventor based in Jamaica Plain, MA (US). He has made significant contributions to the field of nerve regeneration, holding a total of 11 patents. His work focuses on advancing medical technologies that promote neuronal regeneration and healing.

Latest Patents

Among his latest patents, one notable invention addresses nerve regeneration. It has been discovered that the growth factor PDGF, when used in combination with another growth factor such as IGF-I, acts synergistically to promote neuronal regeneration. Another significant invention is a device designed to promote drug-induced nerve regeneration. This invention comprises a guide tube that attaches to the damaged nerve, guiding filaments within the tube, and a therapeutic composition enclosed by the guide tube. Both the guide tube and guiding filaments are made from biologically compatible materials, while the therapeutic composition contains a nerve-growth-stimulating agent dispersed in a matrix-forming material. During treatment, the guide tube is inserted between the ends of lesioned nerves, stimulating axon growth.

Career Highlights

Samuel E. Lynch has worked with esteemed organizations such as the Institute of Molecular Biology, Inc. and Harvard College. His career reflects a commitment to advancing medical science and improving patient outcomes through innovative inventions.

Collaborations

Throughout his career, Lynch has collaborated with notable individuals, including Harry N. Antoniades and Ray C. Williams. These collaborations have contributed to the development of his groundbreaking inventions.

Conclusion

Samuel E. Lynch's contributions to the field of nerve regeneration exemplify the impact of innovative thinking in medicine. His inventions continue to pave the way for advancements in healing and recovery.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]